what
Preimplantation Genetic Testing for Monogenic Disorders (PGT-M) is a specialized technique used to identify genetic abnormalities in embryos that are at risk of inherited single-gene disorders. By screening embryos before implantation, PGT-M enables the selection of those free from specific genetic conditions, thereby reducing the risk of passing on hereditary diseases. This approach is particularly beneficial for patients with a known history of monogenic disorders, as it increases the likelihood of a healthy pregnancy and a child.
how
For PGT-M few cells are carefully biopsied from an embryo at the blastocyst stage (day 5 or 6). These cells are then analyzed for chromosomal abnormalities. Only embryos with the correct number of chromosomes are selected for transfer to the uterus, improving the chances of a healthy pregnancy.
why embryolab
Embryolab Fertility Clinic, a leader in the field of Preimplantation Genetic Testing (PGT), has been providing Monogenic Disorders (PGT-M) since 2007. Our dedicated team of expert clinicians and laboratory specialists meticulously optimizes every step of the PGT-M process, ensuring that patients receive the best possible care and the highest chances of a successful, healthy pregnancy.
